Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.
Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.
Amrize Ltd (AMRZ) insider purchase: On 08/27/2025 Amrize CTO Roald Brouwer acquired 2,000 ordinary shares at $51.88 per share, increasing his beneficial holdings to 5,000 shares. The Form 4 shows the purchase was executed in Swiss francs at CHF 41.835 per share and converted to U.S. dollars using the transaction date exchange rate (USD 1.00 = CHF 0.8064). The filing was signed by Hans Weinburger as attorney-in-fact. The report indicates this was a direct purchase and the filer remains an officer of the company.
Amrize Ltd (AMRZ) insider purchase: Reporting person Jaime Hill, an officer serving as President, Building Materials, acquired 500 ordinary shares on 08/22/2025 at a price of $49.585 per share. After the transaction, Mr. Hill beneficially owned 14,101 shares in a direct capacity. The Form 4 discloses the purchase and the reporting signature by an attorney-in-fact.
Jaime Hill, an officer and listed as President, Building Materials, of Amrize Ltd (AMRZ), reported a purchase of ordinary shares on 08/15/2025. The Form 4 shows a Code P purchase of 4,000 ordinary shares at a price of $51.995 per share, bringing Hill's reported beneficial ownership to 13,601 shares on a direct basis. The filing was submitted by one reporting person and signed by Hans Weinburger as attorney-in-fact on 08/18/2025.
Clark Stephen S, identified as the company's Chief People Officer, reported multiple open-market purchases of Amrize Ltd (AMRZ) ordinary shares executed on 08/15/2025. The transactions incrementally added shares at prices ranging from $51.625 to $51.86, resulting in a total reported beneficial ownership of 5,000 ordinary shares following these purchases. No derivative securities are reported on this form.
The purchases were reported on a single Form 4 filing and were executed in several lots (examples: 100 shares at $51.625, 1,000 shares at $51.82, 1,040 shares at $51.83), showing consistent acquisition prices around $51.63–$51.86 per share.
Amrize Ltd officer Jaime Hill reported a purchase of 4,000 ordinary shares with a reported price of $46.4 per share on 08/08/2025, increasing Hill's beneficial ownership to 9,601 shares. The Form 4 identifies Hill as an officer (President, Building Materials) and shows no derivative transactions in Table II. The transaction is coded P, indicating a purchase.
Amrize Ltd (AMRZ) officer purchased shares on 08/13/2025. The reporting person, identified as an officer serving as Chief Supply Chain Officer, acquired 3,000 ordinary shares at a reported price of $49.63 per share. After the purchase the officer directly beneficially owned 23,232 shares. The purchase was executed in Swiss francs at CHF 39.87 per share and converted using the transaction-day rate of USD 1.00 = CHF 0.8034. The Form 4 was signed by an attorney-in-fact, Hans Weinburger, on 08/14/2025. The filing records a purchase transaction coded "P" and documents the change in direct ownership without additional derivative activity disclosed.
Wilbur Maria Cristina Alapag, a director of Amrize Ltd (AMRZ), reported an equity award on 08/11/2025: a grant of 2,958 restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was issued with a $0 purchase price and will vest on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.
After the reported transaction the reporting person held 3,148 ordinary shares beneficially. The filing is a routine director equity award that documents the grant size, vesting condition, and post-transaction ownership level.
Amrize Ltd director Robert S. Rivkin reported the acquisition of 2,958 ordinary shares in the form of a restricted stock unit (RSU) award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award is recorded at a $0 price and is held directly following the transaction.
The RSUs vest on the earlier of the one-year anniversary of the grant and the issuer's next regular annual meeting of shareholders. The Form 4 shows the reported transaction date as 08/11/2025 and indicates the filing was made by one reporting person with an attorney-in-fact noted on the form.
Amrize Ltd (AMRZ) reports that director Roth Pellanda Katja Nicole received 2,958 ordinary shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The transaction is recorded as an acquisition and the award shows a reported price of $0, indicating the shares were granted rather than purchased.
The award vests on the earlier of the one-year anniversary of the grant date and the issuer's next regular annual meeting of shareholders, and following the transaction the reporting person beneficially owns 2,958 shares directly. No derivative securities were reported in this filing.
Oleas Jurg Amadeo, a director of Amrize Ltd (AMRZ), was granted 2,958 restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan on 08/11/2025 at a reported price of $0.
The award vests on the earlier of the one-year anniversary of the grant or the issuer's next regular annual meeting. After the grant, the reporting person beneficially owns 21,073 ordinary shares directly.